Outcomes From Expanded Qualification Parameters for Bronchoscopic Lung Volume Reduction (BLVR)
This study shows that meaningful benefits occur from the inclusion of patients with lower RV values along with higher FEV1 or 6MWD, using endpoints utilized in the LIBERATE trial treatment group.
Authors
- Frances Muldowney
- Michael J. Weyant (ORCID: https://orcid.org/0000-0002-3333-3106)
- Duy K. Duong (ORCID: https://orcid.org/0000-0003-0567-9457)
- Nancy Collar
- Priya Patel (ORCID: https://orcid.org/0000-0002-2777-6752)
- Melanie P. Subramanian
- Kei Suzuki
- Amit K. Mahajan
- Mayra A. Ochoa Cuba
- Nihar Shah
- Hongkun Wang
Institutions
- Georgetown University (US)
- Inova Fairfax Hospital (US)
- Society of Interventional Radiology (US)
Publication Details
- Journal
- Journal of Bronchology & Interventional Pulmonology
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1097/lbr.0000000000001055
- Primary Topic
- Delphi Technique in Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00